Male Hair Loss: The Evidence, Not the Hype

What actually causes male pattern baldness

Androgenetic alopecia, the clinical name for male pattern hair loss, comes down to three things acting together: a hormone, an enzyme, and an inherited sensitivity in your follicles.

The hormone is dihydrotestosterone, or DHT. Your body makes it from testosterone using an enzyme called 5-alpha-reductase, which lives in the skin, the scalp, and the prostate. DHT is not a villain. It is the same androgen that drives beard growth, deepens the voice at puberty, and grows the prostate. The problem is location-specific. In the hair follicles on the top and front of the scalp, DHT binds to androgen receptors and, over repeated growth cycles, shrinks the follicle. This is called follicular miniaturisation.

Here is what miniaturisation looks like at the follicle. A healthy terminal hair is thick, dark, and grows for years before it sheds. Under DHT pressure, each new growth cycle produces a slightly thinner, shorter, lighter hair, and the resting phase between cycles gets longer. Over years the follicle keeps making finer and finer hairs until it produces only a wispy, barely visible vellus hair, and eventually stops producing a visible hair at all. That is why balding is gradual and why the crown and hairline go first. Those follicles carry the inherited receptor sensitivity. The hair around the sides and back of your head does not, which is exactly why transplanted hair from that region keeps growing on top.

The inheritance is real but not simple. It is polygenic, meaning many genes contribute, and it comes from both sides of your family, not just your mother's father as the old myth goes. If your father and grandfathers thinned early, your odds are higher, but genetics set the probability, not the certainty or the timeline.

The Norwood scale, and why staging changes your expectations

The Norwood scale, sometimes called Norwood-Hamilton, is the standard way clinicians describe how far pattern loss has progressed. It runs from stage 1, a full adolescent hairline, through stage 7, where only a horseshoe band of hair remains around the sides and back. Stages 2 and 3 capture the receding temples and the early hairline changes. Stage 3 vertex and stages 4 through 6 track the crown thinning and the widening gap between hairline and crown. Stage 7 is advanced.

Staging is not vanity paperwork. It sets what any treatment can realistically do for you. Medication works best on follicles that are miniaturising but still alive. On a scalp that has been slick and shiny for years, the follicles are largely gone, and no drug regrows what is no longer there. So a man at Norwood 2 or 3 who starts treatment early has a genuinely different ceiling than a man at Norwood 6 who wants his crown back. The early man is defending a large stock of living follicles. The late man is asking for regeneration that the current evidence does not support. Knowing your stage keeps your expectations honest, which is the whole point.

Why early intervention beats late intervention, every time

This is the most important practical fact on the page. The treatments that work are far better at keeping the hair you have than at bringing back hair you have lost. A miniaturising follicle can often be rescued and pushed back toward producing a thicker hair. A dead follicle cannot. Every year you wait, more follicles cross from the first category into the second.

That changes the decision calculus. The instinct is to wait until the loss is obviously bad before doing anything. The biology rewards the opposite. A man who starts at the first sign of thinning is protecting a large bank of viable follicles. A man who waits until the mirror is undeniable has already lost the follicles that were easiest to save. If you are going to treat at all, the highest-value time to start is earlier than feels urgent.

How the treatments actually rank by evidence

Not all hair loss treatments carry equal proof. Here is the honest tiering, from strongest evidence to weakest.

The pattern is clear. The two pillars with the most FDA-backed evidence are finasteride and minoxidil, and they work on entirely different mechanisms, which is why they are so often used together. Everything below them is either an adjunct, a surgical option, or a device with modest data. None of the tier-one options is available over the counter as a systemic drug except topical minoxidil. Prescription treatments require a licensed provider to determine whether they are appropriate for you.

Realistic timelines, and the maintenance versus regrowth distinction

Hair loss treatment runs on a slow clock, and impatience is the most common reason men quit before they can tell whether anything is working. Nothing visible happens in the first month or two. Do not expect to see a difference before three to six months. A real read on whether a treatment is helping takes about twelve months, because hair grows in cycles measured in months, not weeks.

It also helps to be clear about what success even means. There are two separate goals. Maintenance means keeping the hair you currently have and stopping the decline. Regrowth means recovering hair you have already lost. Maintenance is the realistic, high-probability outcome for most men on treatment. Regrowth happens too, but it is more modest, more variable, and more likely at the crown than at a receded hairline. If you judge treatment purely on whether your hairline marches back to your twenties, you will be disappointed even by a result that is objectively working. The correct benchmark is usually the photo you take today compared with the photo twelve months from now.

What happens when you stop

This is the part men most often miss. Finasteride, dutasteride, and minoxidil are not cures. They suppress an ongoing process. Stop taking them and the process resumes. Within roughly six to twelve months of stopping, you tend to lose not only the hair you gained but also the hair the treatment was protecting, and many men end up back where they would have been had they never treated at all. That makes hair loss treatment a long-term commitment by design, not a course you finish. It is worth deciding up front whether you are prepared to stay on something for years, because starting and stopping repeatedly gives you the side effect risk without the durable benefit.

Is it really pattern baldness, or something that needs a diagnosis

Before you assume every shed hair is androgenetic, rule out the imposters. The most common lookalike is telogen effluvium, a temporary heavy shed that follows a stressor: a major illness, surgery, rapid weight loss, high fever, a new medication, or serious psychological stress, usually two to three months earlier. Telogen effluvium is diffuse, meaning hair thins evenly all over rather than in the male pattern of temples and crown, and it typically recovers on its own once the trigger passes. Pattern loss, by contrast, is patterned and progressive.

Other causes worth a real evaluation include thyroid disease, iron deficiency, certain autoimmune conditions such as alopecia areata, which produces distinct round bald patches, and scarring alopecias that permanently destroy follicles and are a medical emergency for the hair because the window to save them is short. If your loss is patchy, sudden, comes with scalp pain, redness, or scaling, or arrives alongside fatigue, weight change, or other symptoms, that is a reason to see a clinician rather than order a subscription online. Weight and metabolic health can also intersect with hair and hormones, which is one reason overall proactive health and things like weight management are not entirely separate conversations. When the picture is straightforward male pattern loss, a licensed provider can confirm it and discuss whether treatment makes sense for you.

Where OmenRx fits

We do not prescribe, sell, or dispense anything. This site publishes education and points you toward licensed online care partners who can actually evaluate you, confirm the diagnosis, and decide whether a prescription is appropriate. Use these pages to walk in informed. The decision, the prescription, and the monitoring belong to a licensed provider.